Jefferies Abrahams

Jefferies Remains Neutral on Gilead Sciences, Inc. (GILD) and Sarepta Therapeutics Inc (SRPT) Following Expert’s Open Letter and Drug Patent Dispute

Jefferies’ healthcare analysts chimed in on pharmaceutical giant Gilead Sciences, Inc. (NASDAQ:GILD) and rival DMD drug maker Sarepta Therapeutics Inc (NASDAQ:SRPT).

Jason Cohen — March 23, 2016, 12:38 PM EDT

Jefferies Abrahams

Jefferies Remains Neutral on Gilead Sciences, Inc. (GILD) and Sarepta Therapeutics Inc (SRPT) Following Expert’s Open Letter and Drug Patent Dispute

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts